Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Hydration Pharmaceuticals Co. Ltd. ( (AU:HPC) ) has shared an announcement.
Hydration Pharmaceuticals Co. Ltd. announced the placement of 39,500,000 shortfall shares from its pro rata entitlement offer, raising $395,000 before costs. This move brings the total funds raised under the Rights Issue to $558,878.53, potentially strengthening the company’s financial position and supporting its market operations.
More about Hydration Pharmaceuticals Co. Ltd.
The Hydration Pharmaceuticals Company Limited, trading as Hydralyte USA, operates in the hydration solutions industry. The company focuses on providing hydration products, which are likely aimed at improving consumer health and wellness.
Average Trading Volume: 656,711
Technical Sentiment Signal: Sell
Find detailed analytics on HPC stock on TipRanks’ Stock Analysis page.